Purchase Order 75N91020P00817

The Department of Health and Human Services, National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a $29,858 firm-fixed-price purchase order to Miltenyi Biotec, Inc. to provide one Miltenyi Biotec GentleMACS Octo Dissociator with heating units. The equipment will be used to support the work of the NCI's Center for Immuno-Oncology, Laboratory of Tumor Immunology and Biology. There was no set-aside designation for this procurement, and the contract completion date is July...

The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc. for a GentleMACS Octo Dissociator valued at $27,451.25 on June 24, 2026, with completion by December 31, 2026. No set-aside was used. The award is sole-source under FAR 6.302-1 without competitive procurement. Place of performance is Auburn, California. The dissociator supports the Women's Malignancies Branch in generating viable single-cell suspensions from complex tissues, particularly brain tissue, for molecular...

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Miltenyi Biotec, Inc. on January 6, 2021, for a GentleMACS Octo Dissociator, with a ceiling value of $24,984.62 under firm fixed price, no set-aside terms. Performance is located in Auburn, California. The order completed on February 5, 2021. The underlying solicitation was posted December 30, 2020, with a due date of January 5, 2021.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Miltenyi Biotec, Inc. for $24,990.50 on January 25, 2021, for a GentleMACS Octo Dissociator under COVID-19 funding. Performance is at Auburn, California. The order was placed under firm fixed price terms with an ultimate completion date of February 26, 2021. The solicitation posted January 20, 2021, with a due date of January 24, 2021.</p>

<p>The National Heart Lung and Blood Institute issued a purchase order to Miltenyi Biotec, Inc. for $20,680.00 on September 28, 2020, with an ultimate completion date of October 30, 2020. The order procures a GentleMACS Octo Dissociator with heaters for single cell preparations from tissues. Place of performance is Auburn, California. The purchase order is firm fixed price with no set-aside used.</p>

The National Cancer Institute (NCI) has awarded a $31,100 firm-fixed-price purchase order to Miltenyi Biotec, Inc. for the procurement of one Miltenyi Biotec GentleMACS Octo Dissociator with Heating Units. This equipment will be used in support of the Laboratory of Tumor Immunology and Biology (LTIB) at the Center for Immuno-Oncology (CIO) within the NCI's Center for Cancer Research (CCR). The contract has an ultimate completion date of September 30, 2024. Miltenyi Biotec is a global...

<p>The NIH Clinical Center awarded a purchase order to Miltenyi Biotec, Inc. on June 23, 2020, for $24,980.62 to purchase a GentleMACS Octo Dissociator with heaters for dissociating lung tissue samples collected from patient donors into single-cell suspensions. The order carries no set-aside designation and is priced on a firm fixed price basis. Place of performance is Montgomery Village, Maryland. The ultimate completion date is August 26, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc. valued at $22,685.00 for scientific equipment with heaters, with an award date of March 12, 2021 and ultimate completion date of April 12, 2021. Place of performance is Auburn, California. The order is firm fixed price with no set-aside designation.</p>

The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $59,710 purchase order to Miltenyi Biotec, Inc. to deliver two GentleMACS Octo Dissociator units with heaters. The place of performance will be in Auburn, California, and the period of performance is from September 10, 2023 through December 30, 2023. This firm fixed price contract supports NIH/NIAID research efforts through the procurement of specialized...

<p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc., for $16,626.00 on January 7, 2020, with an ultimate completion date of February 7, 2021. The order covers a maintenance agreement on firm fixed price terms. No set-aside was used. Place of performance is Auburn, California.</p>